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Summary
Objective: To study whether transforming growth factor-b1 (TGF-b1) is able to protect human chondrocytes from apoptosis and to analyze the
role of phosphatases in the possible anti-apoptotic effect of TGF-b1.
Methods: Cartilage was obtained from patients with osteoarthritis (OA) who were undergoing joint replacement; normal cartilage was obtained
from cadavers who had no history of joint disease. Chondrocytes stimulated with tumor necrosis factor-a (TNF-a) plus Ro 31-8220 (a speciﬁc
inhibitor of mitogen-activated kinase phosphatase-1 e MKP-1) were employed as an in vitro model of apoptosis. Apoptosis was assessed by
ﬂow cytometry and a cell death immunoassay. Protein phosphatase 2A (PP2A) activity was estimated by measuring the absorbance of a
molybdate:malachite green:phosphate reaction complex. MKP-1, bcl-2 and bax expressions were quantiﬁed by western blot.
Results: In OA cells, TGF-b1 signiﬁcantly reduced the percentage of hypo-diploid chondrocytes, as well as the percentage of internucleosomal
DNA breakage. However, in normal chondrocytes, TGF-b1 did not reduce apoptosis, as assessed by both the percentage of hypo-diploid
chondrocytes and internucleosomal DNA breakage. MKP-1 expression did not show signiﬁcant modulation in OA or normal chondrocytes.
However, PP2A activity was differentially modulated in normal and OA chondrocytes. In OA chondrocytes, PP2A activity was not altered
by TGF-b1 stimulation; however in normal chondrocytes PP2A activity was signiﬁcantly activated by TGF-b1. The preincubation of normal
chondrocytes with TGF-b1 plus the PP2A inhibitor protein, IPP2A, reduced internucleosomal DNA breakage when compared with TGF-b1
stimulation alone. The bcl-2/bax protein ratio was signiﬁcantly higher in TGF-b1 plus IPP2A preincubated normal chondrocytes than in cells
stimulated with TGF-b1 alone.
Conclusion: By manipulating the degree of PP2A activity, these results show the major role that PP2A plays in the outcome of TGF-b1 signal
transduction. These data suggest that PP2A could be a pivotal regulator of anti-apoptotic TGF-b1-induced effects.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Osteoarthritis (OA) is the most common degenerative
chronic joint disease during aging, causing remarkable dis-
ability. OA involves each tissue of the entire joint, that is, the
cartilage, synovium and subchondral bone. At the ﬁnal
stages of the disease, OA is characterized by degradation
of articular cartilage, synovial inﬂammation and proliferation
of new tissue in the joint margins of the subchondral bones
(osteophytes)1. Because one of the major features of OA is
a progressive loss of articular cartilage, research on OA has
focused on understanding the mechanisms that account for
articular cartilage destruction.
Over the last decade, the cell death of chondrocytes has
been considered to be a prominent factor related to the pro-
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1370degradation. Several studies have demonstrated that the
number of apoptotic chondrocytes is higher in severely af-
fected OA cartilage than in less affected cartilage2e5. It
should be noted that the relative contribution of apoptosis
in OA is still difﬁcult to assess because of the chronic nature
of the disease process6. Chondrocyte apoptosis is the ﬁnal
outcome of a very complex interaction of signal networks
(biomechanical, biochemical and genetic factors) which,
taken together, tend to promote cartilage degradation, con-
tributing to the progression of the disease3. In this network
of signals, cytokines play major roles, acting in an autocrine
and paracrine way on the different cells of the joint tissues.
Under normal conditions, the synthesis of cytokines main-
tains joint tissue homeostasis. However, in the osteoarthritic
joint, an imbalance between catabolic and anabolic factors
occurs, with a shift towards catabolism7,8. Therefore, one
approach to treating OA focuses on reversing this metabolic
imbalance by stimulating anabolism.
Transforming growth factor-b1 (TGF-b1) is one of the an-
abolic factors involved in cartilage metabolism. TGF-b1 has
been proven to be beneﬁcial to cartilage because it stimu-
lates the synthesis of extracellular matrix components,
such as proteoglycans and collagen type II9e11. TGF-b1
has also been shown to down-regulate cartilage-degrading
enzymes12,13 and to counteract the catabolic cytokine IL-1,
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promote the proliferation of chondrocytes16,17 and en-
hances the chondrogenic differentiation of bone-marrow de-
rived mesenchymal stem cells18. Therefore, TGF-b1
appears to be a good candidate for cartilage repair.
Phosphatases are enzymes involved in many cellular ac-
tivities. Two major phosphatases in the cell are mitogen-
activated kinase phosphatase-1 (MKP-1) and protein
phosphatase 2A (PP2A). These enzymes are both involved
in the regulation of cell survival, differentiation and apopto-
sis. MKP-1 is a nuclear dual-speciﬁcity phosphatase,
whereas PP2A is a major Ser/Thr phosphatase. Both
MKP-1 and PP2A negatively regulate mitogen-activated
protein kinase (MAPK) signalling19,20. In chondrocytes, ap-
optosis induced by tumor necrosis factor-a (TNF-a) plus Ro
31-8220 (Ro 31; a speciﬁc inhibitor of MKP-1) was due to
MKP-1 down-regulation21. In addition, it has been reported
that the inhibition of PP2A by okadaic acid induced apopto-
sis of chondrocytes22.
In this work, we have studied the ability of TGF-b1 to pro-
tect chondrocytes in culture from TNFþRo 31 induced ap-
optosis in vitro. We showed that TGF-b1 alone reduced
apoptosis in OA, but not in normal chondrocytes. In addi-
tion, we proved that TGF-b1 did not modify the PP2A activ-
ity of OA chondrocytes; however it increased the PP2A
activity in normal chondrocytes. The incubation of normal
chondrocytes with TGF-b1 and PP2A inhibitor protein
(IPP2A) protected the chondrocytes from apoptosis in the
in vitromodel. These data suggest that PP2A could be a piv-
otal regulator of anti-apoptotic TGF-b1-induced effects.Materials and methodsCHONDROCYTE CULTURESNormal human knee cartilage was obtained at necropsy from adult
cadavers (n¼ 15; age¼ 57.5 21.3 years old) who had no history of joint
disease and who had macroscopically normal cartilage. Human OA cartilage
was obtained from patients (n¼ 13; age¼ 72.8 10.3 years old) who were
undergoing joint replacement surgery. The cartilage surfaces were ﬁrst
rinsed with sterile saline. Scalpels were used to cut vertically from the
cartilage surface onto the subchondral bone in parallel sections 5 mm apart.
These cartilage strips were then resected from the subchondral bone. The
tissue was incubated at 37 C with trypsin for 10 min. After removing the
trypsin solution, the cartilage slices were treated with type IV collagenase
(2 mg/ml; SigmaeAldrich, St Louis, MO) for 12e16 h. Chondrocytes were
recovered and plated at high density (4 106 per 162 cm2 ﬂask; Costar,
Cambridge, MA) in Dulbecco’s Modiﬁed Eagle’s Medium (DMEM; Life
Technologies, Paisley, UK) supplemented with 100 U/ml penicillin, 100 mg/mlFig. 1. Overview of experimental design. Human knee articular chondroc
with TGF-b1 (12.5 ng/ml) or simultaneously with TGF-b1 and the PP2A in
were then induced to undergo apoptosis with simultaneous treatment wi
which apoptosis was evaluatestreptomycin, 1% glutamine, and 10% fetal bovine serum (Life Technolo-
gies). The chondrocyte cultures were incubated at 37 C in a humidiﬁed
gas mixture containing 5% CO2 balanced with air. Chondrocytes used in
these experiments were at conﬂuence in primary culture at 2e3 weeks.IN VITRO MODEL OF APOPTOSISTo carry out this study, two in vitro models to induce chondrocyte apopto-
sis have been tested and standardized in our laboratory. One uses the com-
bination of TNF-a and actinomycin D and the other one uses TNF-a plus Ro
31. Because the main objective of this study was to analysis the role of phos-
phatases (MKP-1 and PP2A) in the possible anti-apoptotic effect of TGF-b1,
we have employed the combination of TNF-a at 10 ng/ml and Ro 31 (a spe-
ciﬁc inhibitor of MKP-1) at 5 mM for 16 h.
To analyze the anti-apoptotic effect of TGF-b1, chondrocytes were pre-
treated with TGF-b1 at several doses (1.25, 5, 12.5 ng/ml) for different
time periods (24, 72, 120 h). After several experiments, the use of TGF-b1
at 12.5 ng/ml for 120 h was selected as optimal, in terms of protection
against induced apoptosis in this in vitro model (Fig. 1).
In experiments with normal chondrocytes, the IPP2A at 0.1 nM
(SigmaeAldrich) was added alone or simultaneously with TGF-b1 during
pre-treatment (Fig. 1).QUANTITATION OF HYPO-DIPLOID DNATo determine the percentage of the hypo-diploid DNA cell population, chon-
drocytes were seeded at 2.5 105 per well in a 12-well culture plate in 2 ml
DMEM. After stimulation, the cells were trypsinized and resuspended in a solu-
tion of 100 mg/ml propidium iodide (PI, SigmaeAldrich), 10 mg/ml RNAse A
(Roche Diagnostics, Indianapolis, IN, USA), 0.05% NP-40 (SigmaeAldrich)
in phosphate buffered saline (PBS), and incubated for an hour at 4 C. The
analysis was made using a FACScan (Becton and Dickinson, Mountain
View, CA, USA) with a dichromatic mirror of 560 nm and a ﬁlter of 600 nm
and Cell-Quest software (Becton Dickinson).QUANTITATION OF INTERNUCLEOSOMAL DNA
FRAGMENTATIONTo measure DNA fragmentation, chondrocytes were seeded at 5 104
per well in a 96-well culture plate in 100 ml DMEM medium. After incubation,
the nucleosomes were detected in the sample using the cell death detection
enzyme-linked immunosorbent assay (ELISA) (Roche Diagnostics) accord-
ing to the manufacturer’s instructions. The results are expressed as the
mean fold-increase in DNA fragmentation.WESTERN BLOTTINGAfter appropriate stimulation, the cells were washed in ice cold PBS, pH
7.5, and lysed in 0.2 M TriseHCl, pH 6.8 containing 2% sodium dodecyl sul-
phate (SDS), 20% glycerol, 1 mg/ml protease inhibitor cocktail (Sigmae
Aldrich), 1 mM phosphatase inhibitor cocktail (SigmaeAldrich), and 1 mM
phenyl methyl sulphonyl ﬂuoride (SigmaeAldrich). Protein concentrations
were determined using a BCA reagent assay (Pierce Chemical Co, Rock-
ford, IL, USA). The protein extract (30e50 mg) was resolved on 12.5%ytes isolated from cadavers or patients with OA were preincubated
hibitor protein IPP2A (0.1 nM; normal for 120 h). The chondrocytes
th TNF-a (10 ng/ml) and Ro 31-8220 (Ro 31; 5 mM) for 16 h, after
d by several methods.
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branes (Immobilon P, Millipore Co, Bedford, MA, USA). The membranes
were blocked in Tris-buffered saline, pH 7.4 containing 0.1% Tween-20,
and 6% bovine serum albumin for 60 min at room temperature. The cells
were then incubated overnight with mouse antihuman bcl-2 (Trevigen, Inc),
bax (R&D, Abingdon, UK) or MKP-1 (Santa Cruz Biotechnology, Inc, Santa
Cruz, CA), in fresh blocking solution at 4 C. After washing, bcl-2 and bax
proteins were detected by incubation with anti-mouse IgG, horseradish
peroxidase linked whole antibody (from sheep) (1:1000) (Amersham, Buck-
inghamshire, UK), while MKP-1 protein was detected by incubation with anti-
rabbit IgG, horseradish peroxidase linked whole antibody (from goat)
(1:1000) (Amersham, Buckinghamshire, UK) and developed using an ECL
chemiluminescence kit (Amersham, Buckinghamshire, UK). To assure that
equal amounts of total proteins (bcl-2, 30 mg; bax and MKP-1, 50 mg) were
placed in each lane, we also hybridized each membrane with anti-a-tubulin
(SigmaeAldrich). The integrated optical density (IOD) of the signals was
semiquantiﬁed and expressed as the ratio of IOD from the tested proteins
to IOD from a-tubulin. The data are expressed as the meanSD (standard
deviation) of the percentage ratio of the control.PROTEIN PHOSPHATASE ACTIVITY MEASUREMENTSChondrocytes were seeded at 5 104 per well in a 96-well culture plate in
100 ml DMEM medium. After appropriate stimulation, the cells were trypsi-
nized and then resuspended and lysed by ultrasound treatment in 25 mM
Tris (pH 7.5), 10 mM b-mercaptoethanol, 2 mM EDTA, 1 mM benzamidine,
1 mM phenyl methyl sulphonyl ﬂuoride and 1 mM protease inhibitor cocktail
(SigmaeAldrich). The PP2A activity of the protein extract was measured with
a Ser/Thr phosphatase assay according to the manufacturer’s recommenda-
tions (Promega, Madison, WI, USA).STATISTICSThe data are expressed as the mean S.E.M. (standard error of the mean)
from n determinations or as representative results, as indicated. TheFig. 2. Characterization of TGF-b1 protection by PI ﬂow cytometry. Panel
stimulated simultaneously for 16 h with TNF-a and Ro 31, with or withou
signiﬁcantly increased levels of induced apoptosis after TNF-a and Ro 3
pre-incubated with TGF-b1 cells showed a signiﬁcant reduction in apopto
tiﬁcation of apoptotic cells among human normal chondrocytes stimulated
niﬁcantly increased levels of induced apoptosis, when compared to basal
not show a signiﬁcant reduction of apoptosis (*p< 0.05). The results ar
experiments performstatistical software program, SPSS (Version 14.0, SPSS, Chicago, IL,
USA), was used to perform analysis of variance or Tukey tests. Differences
were considered to be signiﬁcant at p< 0.05.ResultsEFFECT OF TGF-b ON CHONDROCYTE SURVIVALThe ﬁrst set of experiments was carried out to conﬁrm
that simultaneous stimulation with TNF-a (10 ng/ml) and
Ro 31 (5 mM) for 16 h induced apoptosis in both OA and
normal chondrocytes. The determination of the apoptotic
cell population by staining with PI showed that simulta-
neous treatment with TNF and Ro 31 induced a signiﬁcantly
(p< 0.05) increased hypo-diploid apoptotic cell population,
when compared to basal conditions, in OA (18.6% vs 7.0%)
and in normal (20.3% vs 5.3%) chondrocytes (Fig. 2A, B).
Quantiﬁcation of DNA internucleosomal fragmentation
signiﬁcantly (p< 0.01) increased six-fold in both OA and
normal chondrocytes simultaneously stimulated with TNF-
a plus Ro 31 (Fig. 3A, B). Furthermore, morphologic analy-
ses showed typical features of nuclei undergoing the
apoptotic process, such as chromatin condensation and
DNA fragmentation (data not shown).
The next set of experiments was designed to demonstrate
theeffect of TGF-b1on this apoptotic in vitromodel.WhenOA
chondrocytes were pretreated with TGF-b1 (12.5 ng/ml) for
120 h, apoptosis was signiﬁcantly reduced. The evaluation
of the apoptotic population by ﬂow cytometry showed thatA: Quantiﬁcation of apoptotic cells among human OA chondrocytes
t pre-incubation for 120 h with TGF-b1. OA chondrocytes showed
1 treatment, when compared to the basal level. OA chondrocytes
sis after exposure to TNF-a and Ro 31 treatment. Panel B: Quan-
for 16 h with TNF-a and Ro 31. Normal chondrocytes showed sig-
levels. In normal chondrocytes, the TGF-b1 pre-incubated cells did
e from ﬁve different donors of chondrocytes and ﬁve independent
ed in duplicate.
Fig. 3. Characterization of the protective effect of TGF-b1 by DNA fragmentation analysis. Panel A: Human OA chondrocytes were simulta-
neously stimulated for 16 h with TNF-a (10 ng/ml) plus Ro 31-8220 (Ro 31; 5 mM) with or without pre-incubation with TGF-b1 (12.5 ng/ml) for
120 h. OA chondrocytes treated only with TNF-a plus Ro 31 showed a signiﬁcantly increased level of DNA fragmentation, when compared to
the basal level. However, OA chondrocytes pre-incubated with TGF-b1 before exposure to TNF-a plus Ro 31 showed a signiﬁcant reduction in
DNA fragmentation when compared to the TNF-a plus Ro 31-treated cells without pre-incubation with TGF-b1. Panel B: Normal human chon-
drocytes were stimulated for 16 h with TNF-a plus Ro 31, with or without preincubation with TGF-b1 for 120 h. Normal chondrocytes treated
only with TNF-a plus Ro 31 showed a signiﬁcantly increased level of DNA fragmentation, when compared to the basal level. However, normal
chondrocytes pre-incubated with TGF-b1 before exposure to TNF-a plus Ro 31 TGF-b1 did not show a signiﬁcant reduction in DNA fragmen-
tation (**p< 0.01; *p< 0.05). The results are from ﬁve different donors of chondrocytes and ﬁve independent experiments performed in du-
plicate and are expressed as the mean fold-increase in DNA fragmentation.
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partially blocked by TGF-b1 (8.9%) (Fig. 2A), and that the
quantiﬁcation of DNA internucleosomal fragmentation was
also reduced (Fig. 3A). Interestingly, similar experiments
were carried out in normal chondrocytes, but TGF-b1 did
not reduce the apoptosis induced by the simultaneous stimu-
lation with TNF-a plus Ro 31 (Figs. 2B, 3B). In addition, the
anti-apoptotic effect of TGF-b1 onOA chondrocyte was dem-
onstrated by qualitative assessment of chromatin condensa-
tion and fragmentation by ﬂuorescence (data not shown).EFFECT OF TGF-b1 ON MKP-1 AND PP2ABecause phosphatases are involved in the regulation of
cell survival, we decided to study the effect of TGF-b1 on
two major phosphatases in the cell, MKP-1 and PP2A.
The modulation of MKP-1 was evaluated at several times
after TGF-b1 stimulation by western blot in both normal
and OA chondrocytes. The results showed that TGF-b1
was not able to modulate MKP-1 expression in normal or
in OA chondrocytes when compared to the basal levels
(Fig. 4A). However, TGF-b1 increased PP2A activity in nor-
mal chondrocytes after 30 min (135.2 23.1%) and 3 h
(156.2 33.5%) of stimulation (Fig. 4B). In contrast, PP2A
activity was not altered by TGF-b1 in OA chondrocytes at
30 min or 3 h (111.5 16.5% and 93.4 29.2%, respec-
tively) (Fig. 4B).Based on our ﬁndings that preincubation with TGF-b1
has different blocking effects on the apoptosis induced by
TNF-a plus Ro 31 in normal and OA chondrocytes and
that TGF-b1 causes different modulation of PP2A activity
in normal and OA chondrocytes, we decided to study the ef-
fect of PP2A inhibition on normal chondrocyte survival. The
inhibition of PP2A, using a speciﬁc inhibitor (IPP2A), in-
duced apoptosis in normal chondrocytes at a range similar
to that induced by the treatment with TNF-a plus Ro 31 and
it increased the apoptosis induced by TNF-a plus Ro 31
(Fig. 5A). Interestingly, stimulation of chondrocytes with
TGF-b1 reduced the apoptosis induced by IPP2A (0.1 nM)
(Fig. 5B). Furthermore, when TGF-b1 was combined with
IPP2A the levels of DNA fragmentation induced by TNF-
a plus Ro 31 were signiﬁcantly reduced to levels similar
to basal (p< 0.01) (Fig. 5B). As previously conﬁrmed,
TGF-b1 alone did not show signiﬁcant protection against
the apoptosis induced by TNF-a plus Ro 31 in the absence
of IPP2A (Fig. 5B).EFFECT OF TGF-b1 ON THE bcl-2/bax RATIOSome of the bcl-2 family of proteins, which is involved in
the apoptosis pathway, are dephosphorylated by PP2A.
Our results showed that in normal chondrocytes, preincuba-
tion with TGF-b1 for 120 h, followed by treatment with TNF-
a plus Ro 31, induced signiﬁcant synthesis of bax protein
Fig. 4. Effect of TGF-b1 on phosphatases. Panel A: MKP-1. The
quantiﬁcation of levels of MKP-1 by western blot analysis in normal
and OA chondrocytes simultaneously stimulated for 16 h with TNF-
a (10 ng/ml) plus Ro 31-8220 (Ro 31; 5 mM) after pre-incubation
with TGF-b1 (12.5 ng/ml) for 120 h. The levels of MKP-1 were not
altered at any of the times evaluated in either normal or OA chon-
drocytes. The levels of MKP-1 were also quantiﬁed after a second
administration of TGF-b1 (72 h; data not shown) with similar results.
The data are representative from three experiments. Panel B:
PP2A. The PP2A activity was measured using a Ser/Thr phospha-
tase assay in OA and normal chondrocytes after pre-incubation
with TGF-b1 (12.5 ng/ml). The histograms show that TGF-b1 stim-
ulated PP2A activity over time (30 min and 3 h) in normal cells, but
not in OA cells. *p< 0.05 when compared to the basal level. PP2A
activity was also measured after the second administration of TGF-
b1 (72 h; data not shown) with similar results. The results are from
ﬁve different donors of chondrocytes and ﬁve independent experi-
ments performed in triplicate.
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combination of IPP2A and TGF-b1 had the opposite effect,
inducing signiﬁcant protein synthesis of bcl-2 but did not
bax (Fig. 6A, B). The interpretation of the results as the ratio
of the protein levels of bcl-2/bax showed that pre-incubation
with TGF-b1 plus IPP2A signiﬁcantly increased the bcl-2/
bax ratio in normal chondrocytes (1.21 0.08). However
pre-incubation with TGF-b1 alone decreased the ratio
(0.72 0.08) (Fig. 6C).Discussion
This study evaluates the ability of TGF-b1 to protect hu-
man articular chondrocytes from apoptosis induced by stim-
ulation with TNF-a plus Ro 31 in an in vitro model. We
establish that preincubation with TGF-b1 and TGF-b1 plusIPP2A protect OA and normal chondrocytes, respectively,
from TNF-a plus Ro 31 induced apoptosis. The results
were conﬁrmed by three different techniques: ﬂow cytometry
to quantify hypo-diploid cells, ELISA to measure DNA frag-
mentation and immunoﬂuorescence microscopy to analyze
nuclear morphology (data not shown). To carry out this study
we have employed a validated in vitro model to induce apo-
ptosis in chondrocytes. We have used chondrocytes in cul-
ture, which were induced to undergo apoptosis with
exposure to TNF-a plus Ro 31. Ro 31 is a synthetic molecu-
lar analog of staurosporin, which inhibits kinases, such as
protein kinase C, or phosphatases, such as MKP-1. It has
been previously demonstrated that this in vitro model, as
well as the combination of TNF-a plus actinocycin D, is
adequate to study apoptosis in chondrocytes21e24.
To our knowledge, little is known about the effect of TGF-
b1 on chondrocyte survival. However, in other type of cells,
TGF-b1 has a dual role. Proapoptotic responses to TGF-b1
have been observed in cells from several tumoral and pri-
mary cells25,26, while, on the other hand, TGF-b1 protects
a variety of cells, including microglia27, human synovial
cells28, osteoblasts29, hepatic cells30 and mammary epithe-
lial cells31,32, from apoptosis. TGF-beta signals predomi-
nantly through two receptors, TGF-beta-RI (ALK5) and
TGF-beta-RII. TGF-beta binds to the type II receptor, re-
cruits and phosphorylates the type I receptor and subse-
quently activates its receptor Smad, Smad2 or Smad3, by
phosphorylation33. Thereafter, the phosphorylated Smad2
or Smad3 forms a complex with the common-Smad,
Smad4. The complex is subsequently translocated to the
nucleus where TGF-beta responsive genes are tran-
scribed33. In this study, we have found different effects of
TGF-b1 on normal and OA human chondrocytes. These dif-
ferential responses to TGF-b1 between OA and normal
chondrocytes have been previously documented. Others
authors have also found discrepancies between OA carti-
lage and healthy cartilage with respect to TGF-beta expres-
sion. Gomez-Camarillo et al. showed that TGF-beta1
receptors were very scarce in experimental OA34. The null
phosphorylation of Smad2, a mediator of TGF-b1 signalling,
in OA chondrocytes, or a lower expression of TGF-b1 re-
ceptors, also in OA chondrocytes, seems to account for
these different responses between OA and normal
chondrocytes32,33.
We have attempted to ﬁnd new mediators of the signal in-
side the cell that could account for the diverse anti-apoptotic
effects in OA and normal chondrocytes. Two major phos-
phatases, MKP-1 and PP2A, involved in the regulation of
cell survival, differentiation and apoptosis were studied. Lit-
erature shows that MKP-1 is activated by TGF-b signalling
implicated in different functions, such as in regulating hu-
man toll-like receptors and key host defence receptors
that recognize invading bacterial pathogens35,36. However,
because MKP-1 expression was not altered after TGF-b1
stimulation in either normal or OA chondrocytes, we have
eliminated this phosphatase as a possible explanation for
the different effects of TGF-b1.
Regarding to PP2A, it has proved that TGF-b uses
Smad4-independent, (PP2A/PP2A-like dependent) alterna-
tive signalling pathways for apoptosis induction in lym-
phoma cells37. We think that a similar mechanism is
involving in the normal chondrocytes, as TGF-b produces
an increment in PP2A activity. This increase is proposed
as a mechanism through TGF-b could exert proapoptotic ef-
fects. In our model, TGF-b1 differentially modulated PP2A
activity in OA and normal chondrocytes. TGF-b1 signiﬁ-
cantly induced PP2A activity in normal chondrocytes,
Fig. 5. Effect of the inhibition of PP2A on normal chondrocytes. (A) The speciﬁc inhibition of PP2A with IPP2A induced signiﬁcant levels of
apoptosis in normal chondrocytes, similar to those induced by treatment with TNF-a (10 ng/ml) plus Ro 31-8220 (Ro 31; 5 mM) alone. (B)
Preincubation with TGF-b1 (12.5 ng/ml) for 120 h blocked the IPP2A induced apoptosis. The simultaneous preincubation of normal chondro-
cytes with TGF-b1 and IPP2A followed by treatment with TNF-a plus Ro 31 signiﬁcantly reduced the apoptosis induced by the combination of
TNF-a plus Ro 31 alone (*p< 0.01). The results are from ﬁve different donors of chondrocytes and ﬁve independent experiments performed at
least in duplicate and are expressed as the mean fold-increase in DNA fragmentation.
1375Osteoarthritis and Cartilage Vol. 16, No. 11whereas PP2A activity in OA cells was not affected. Inter-
estingly, the addition of IPP2A to TGF-b1-stimulated normal
chondrocytes, prior to TNF-a plus Ro 31-induced apoptosis,
led to protection from apoptosis. These results suggest that
the stimulation of PP2A activity through TGF-b1 could block
other anti-apoptotic pathways, which could otherwise be ac-
tivated by TGF-b1, and to suppress the effect of TGF-b1 to
block apoptosis in normal chondrocytes stimulated with
TNFþRo-31 (Fig. 7). The ﬁndings showing that the inhibi-
tion of PP2A induces chondrocyte apoptosis and that TGF-
b1 is able to block this effect also support the idea that
TGF-b1 may protect against apoptosis when PP2A is in-
hibited. This hypothesis is supported by multiple works dem-
onstrating a positive regulatory role for PP2A in apoptosis
by activating pro-apoptotic and inhibiting anti-apoptotic pro-
teins by dephosphorylation (see review in Ref. 38). TGF-b1
signal transduction has been modulated by PP2A in differ-
ent contexts and cell types. TGF-b1 can inhibit cell cycle
progression by decreasing phosphorylation of cyclic AMP-
responsive element-binding protein (CREB) and activating
transcription factor-1 (ATF-1), through the direct activation
of PP2A, leading to inhibition of cyclin A39. In mesenchymal
cells, TGF-b1 affects transcriptional regulation through de-
phosphorylation of retinoblastoma protein by PP2A activa-
tion40. Furthermore, TGF-b1 has been proven to activate
PP2A gene expression in a mouse mammary gland epithe-
lial cell line41.Many of the apoptotic-related proteins regulated by PP2A
belong to the bcl-2 family of proteins. For this reason, we de-
cided to study the modulation of bcl-2 and bax by TGF-b1.
We show that in normal chondrocytes, TGF-b1 is not able
to induce expression of bcl-2 protein, but upregulates bax
protein, causing a signiﬁcant reduction of the bcl-2/bax pro-
tein ratio (which works as a rheostat that determines the sur-
vival or death of cells following an apoptotic stimulus)42.
Interestingly, the addition of IPP2A to TGF-b1 upregulated
the expression of bcl-2 protein and reduced its effect on
bax protein, thus causing a signiﬁcant increase in the bcl-2/
bax protein ratio. These results correlate with the apoptotic
protection showed by TGF-b1 plus IPP2A, compared with
the lower levels of cell protection in cells not treated with
IPP2A. These data suggest that PP2A inhibition protects
against apoptosis in TGF-b1-stimulated normal chondro-
cytes, mediated by the relative increase of bcl-2 levels rela-
tive to those of bax (Fig. 6). These ﬁndings are in
concordance with other reported data showing that the
anti-apoptotic function of bcl-2 is, at least partially, inacti-
vated as PP2A dephosphorylates Ser7043, while bad is rap-
idly dephosphorylated by PP2A after interleukin-3 (IL-3)
withdrawal44. The same happenswith bax, as C(2)-ceramide
treatment, a potent PP2A activator, reduced the nicotine-in-
duced bax phosphorylation of residue Ser184, subsequently
activating its proapoptotic function, suggesting that PP2A
may function as a physiological bax phosphatase45.
Fig. 6. Effect of TGF-b1 and PP2A inhibitory protein (IPP2A) on the bcl-2/bax ratio. Quantiﬁcation of the protein levels of bcl-2 (Panel A) and
bax (Panel B) detected by western blot analysis in normal chondrocytes preincubated for 120 h with TGF-b1-alone or with TGF-b1þ IPP2A,
and then stimulated with TNF-a (10 ng/ml) plus Ro 31-8220 (Ro 31; 5 mM) for 16 h. The expressions of bax was signiﬁcantly upregulated by
preincubation with TGF-b1 ( p< 0.05 vs control), whereas simultaneous stimulation with TGF-b1 and IPP2A upregulated bcl-2 expression
( p< 0.05 vs control). Panel C: The ratio of bcl-2/bax proteins is signiﬁcantly higher in normal chondrocytes simultaneously preincubated
with TGF-b1 and IPP2A, when compared to preincubation with TGF-b1 alone. The values are the mean of three samples from three different
donors of chondrocytes (*p< 0.05; **p< 0.01).
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Fig. 7. Flowchart showing the hypothesized pivotal role of phospha-
tase 2A (PP2A) in the signal pathway of TGF-b1. In normal chon-
drocytes, TGF-b1 upregulates PP2A activity, decreasing the
bcl-2/bax ratio. Importantly, the speciﬁc inhibition of PP2A with
IPP2A, simultaneous with TGF-b1 stimulation, produced an in-
crease in the ratio of bcl-2/bax proteins, contributing to cell protec-
tion. In OA chondrocytes, TGF-b1 does not upregulate the level of
PP2A activity; thus the bcl-2/bax ratio is increased (previously re-
porting), contributing to cell protection.
1377Osteoarthritis and Cartilage Vol. 16, No. 11This hypothesis, demonstrated in normal chondrocytes,
could also apply to the effect of TGF-b1 on OA chondrocytes
(Fig. 7). TGF-b1 in OA chondrocytes was able to protect the
cells from apoptosis induced by TNF-a plus Ro 31. This
result is in concordance with the non-effect of TGF-b1 on
PP2A activity, which was not able to induce the pro-apoptotic
activity of PP2A. Furthermore, because it has been reported
previously that the expression of Bcl-2 protein in OA cells is
higher than that in normal cells4,46,47, and because we have
demonstrated that TGF-b1 does not induce PPA2 activity we
postulate that TGF-b in OA chondrocytes may protect from
apoptosis through the increment of bcl-2/bax ratio.
In conclusion, because TGF-b1 is able to reduce the level
of apoptosis induced by TNF-a plus Ro 31 when PP2A is
inhibited, PP2A is involved in the mechanism of action of
TGF-b1. Because TGF-b1 plus IPP2A increased the bcl-
2/bax ratio, the bcl-2 protein family could be the substrate
for PP2A involved in the TGF-b1 effect on chondrocyte sur-
vival. These data suggest that PP2A, or some of its sub-
strates, could become interesting targets to obtain better
therapeutic TGF-b1 responses in OA.Conﬂict of interest
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